Jacek Jemielity
age 53Currently 2 roles in 1 KRS entity. In the KRS since 2019.
Roles
| Entity | Role | Since | Address |
|---|---|---|---|
Explorna Therapeutics sp. z o.o. |
since May 16, 2019 | ul. Żwirki I Wigury 93/2157, 02-089 Warszawa |
Connections graph
Change history
| Date | Event | Details | Entity |
|---|---|---|---|
| Share capital increased | Share capital: PLN 8,350 → PLN 9,100 Explorna Therapeutics sp. z o.o. | Explorna Therapeutics sp. z o.o. | |
| Share capital increased | Share capital: PLN 7,600 → PLN 8,350 Explorna Therapeutics sp. z o.o. | Explorna Therapeutics sp. z o.o. | |
| Share capital increased | Share capital: PLN 6,850 → PLN 7,600 Explorna Therapeutics sp. z o.o. | Explorna Therapeutics sp. z o.o. | |
| Shareholding changed | Partner: 44% of shares worth PLN 2,200 → 30.66% of shares worth PLN 2,100 Explorna Therapeutics sp. z o.o. | Explorna Therapeutics sp. z o.o. | |
| Share capital increased | Share capital: PLN 6,250 → PLN 6,850 Explorna Therapeutics sp. z o.o. | Explorna Therapeutics sp. z o.o. | |
| Share capital increased | Share capital: PLN 5,000 → PLN 6,250 Explorna Therapeutics sp. z o.o. | Explorna Therapeutics sp. z o.o. | |
| Shareholding changed | Partner: 49% of shares worth PLN 2,450 → 44% of shares worth PLN 2,200 Explorna Therapeutics sp. z o.o. | Explorna Therapeutics sp. z o.o. | |
| Company founded | President of the Management Board, Partner (49% of shares worth PLN 2,450) Explorna Therapeutics sp. z o.o. | Explorna Therapeutics sp. z o.o. |
Business scale
Total for the entities where the person sat on the management board or held shares, for the years in office.
Signals in related entities
| Signal | Entities |
|---|---|
Bankruptcy or restructuring | None |
Liquidation | None |
Sanctions list | None |
Inactive entity | None |
Connected people
| Person | Shared entity | Period | |
|---|---|---|---|
Jakub Adam Gołąbage 54 | Explorna Therapeutics sp. z o.o. | since May 16, 2019 | |
Mateusz Michał Gołąbage 53 | Explorna Therapeutics sp. z o.o. | since Jan 15, 2021 | |
Tomasz Piecage 57 | Explorna Therapeutics sp. z o.o. | since Jan 15, 2021 |